NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,154 | -2.3% | 23,502 | +0.3% | 0.00% | – |
| Q2 2023 | $174,091 | +25.6% | 23,431 | +17.1% | 0.00% | – |
| Q1 2023 | $138,662 | -38.3% | 20,009 | -8.5% | 0.00% | – |
| Q4 2022 | $224,772 | -31.1% | 21,865 | +22.0% | 0.00% | – |
| Q3 2022 | $326,000 | -67.2% | 17,923 | -7.2% | 0.00% | -100.0% |
| Q2 2022 | $994,000 | -24.1% | 19,319 | +8.6% | 0.00% | 0.0% |
| Q1 2022 | $1,310,000 | -51.4% | 17,789 | -5.5% | 0.00% | -50.0% |
| Q4 2021 | $2,694,000 | -72.1% | 18,834 | -59.6% | 0.00% | -66.7% |
| Q3 2021 | $9,671,000 | +85.0% | 46,649 | +89.5% | 0.01% | +100.0% |
| Q2 2021 | $5,227,000 | +31.8% | 24,616 | +12.6% | 0.00% | 0.0% |
| Q1 2021 | $3,965,000 | +80.3% | 21,871 | +10.9% | 0.00% | +50.0% |
| Q4 2020 | $2,199,000 | +33.5% | 19,723 | +29.8% | 0.00% | +100.0% |
| Q3 2020 | $1,647,000 | +16.1% | 15,196 | -10.8% | 0.00% | 0.0% |
| Q2 2020 | $1,419,000 | – | 17,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,758,833 | $396,649,000 | 7.73% |
| TSP Capital Management Group, LLC | 72,575 | $6,049,000 | 2.58% |
| Beirne Wealth Consulting Services, LLC | 22,250 | $1,855,000 | 1.51% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 93,000 | $7,752,000 | 1.41% |
| Rock Springs Capital Management LP | 570,598 | $47,559,000 | 1.30% |
| Sargent Investment Group, LLC | 38,059 | $3,033,000 | 1.14% |
| Harvest Investment Services, LLC | 19,580 | $1,631,000 | 0.97% |
| Parkman Healthcare Partners LLC | 40,000 | $3,334,000 | 0.94% |
| EAM Investors, LLC | 39,055 | $3,255,000 | 0.72% |
| EAM Global Investors LLC | 17,774 | $1,481,000 | 0.67% |